Correlation Between GM and NewAmsterdam Pharma
Can any of the company-specific risk be diversified away by investing in both GM and NewAmsterdam Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GM and NewAmsterdam Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between General Motors and NewAmsterdam Pharma, you can compare the effects of market volatilities on GM and NewAmsterdam Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GM with a short position of NewAmsterdam Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of GM and NewAmsterdam Pharma.
Diversification Opportunities for GM and NewAmsterdam Pharma
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between GM and NewAmsterdam is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding General Motors and NewAmsterdam Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewAmsterdam Pharma and GM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Motors are associated (or correlated) with NewAmsterdam Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewAmsterdam Pharma has no effect on the direction of GM i.e., GM and NewAmsterdam Pharma go up and down completely randomly.
Pair Corralation between GM and NewAmsterdam Pharma
Allowing for the 90-day total investment horizon GM is expected to generate 1.6 times less return on investment than NewAmsterdam Pharma. But when comparing it to its historical volatility, General Motors is 1.52 times less risky than NewAmsterdam Pharma. It trades about 0.15 of its potential returns per unit of risk. NewAmsterdam Pharma is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 1,623 in NewAmsterdam Pharma on August 28, 2024 and sell it today you would earn a total of 461.00 from holding NewAmsterdam Pharma or generate 28.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
General Motors vs. NewAmsterdam Pharma
Performance |
| Timeline |
| General Motors |
| NewAmsterdam Pharma |
GM and NewAmsterdam Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GM and NewAmsterdam Pharma
The main advantage of trading using opposite GM and NewAmsterdam Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GM position performs unexpectedly, NewAmsterdam Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewAmsterdam Pharma will offset losses from the drop in NewAmsterdam Pharma's long position.The idea behind General Motors and NewAmsterdam Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| NewAmsterdam Pharma vs. Eliem Therapeutics | NewAmsterdam Pharma vs. Scpharmaceuticals | NewAmsterdam Pharma vs. Milestone Pharmaceuticals | NewAmsterdam Pharma vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |